Clinical Trials Browser

Phase 2 × Clofarabine × 90 days × Clear all

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT03136146 2026-02-17

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Phase 2 Recruiting

42 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05917405 2026-01-30

FLUCLORIC

Phase 2 Recruiting

302 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06252870 2026-01-26

CY-MET-RIC

Phase 2 Recruiting

82 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

Clinical Trials

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

FLUCLORIC

CY-MET-RIC